Proliferation of retrovirally transduced CFU-E cells after incubation with increasing Epo-concentration (Figure 5c)
Cobertura |
DATE/TIME START: 2007-11-26T00:00:00 * DATE/TIME END: 2007-11-26T00:00:00 |
---|---|
Data(s) |
07/02/2012
|
Resumo |
Data contain source data for Figure 5c from Schilling et al., 2009. Cell fate decisions are regulated by the coordinated activation of signalling pathways such as the extracellular signal-regulated kinase (ERK) cascade, but contributions of individual kinase isoforms are mostly unknown. The authors combined quantitative data from erythropoietin-induced pathway activation in primary erythroid progenitor (colony-forming unit erythroid stage, CFU-E) cells with mathematical modelling, in order to predict and experimentally confirmed a distributive ERK phosphorylation mechanism in CFU-E cells. The authors found evidences that double-phosphorylated ERK1 attenuates proliferation beyond a certain activation level, whereas activated ERK2 enhances proliferation with saturation kinetics. Retrovirally transduced CFU-E cells were incubated with increasing Epo concentrations for 14 h and proliferation was measured by [3H]-thymidine incorporation. |
Formato |
text/tab-separated-values, 800 data points |
Identificador |
https://doi.pangaea.de/10.1594/PANGAEA.775548 doi:10.1594/PANGAEA.775548 |
Idioma(s) |
en |
Publicador |
PANGAEA |
Relação |
Schilling, Marcel; Maiwald, Thomas; Hengl, Stefan; Winter, Dominic; Kreutz, Clemens; Kolch, Walter; Lehmann, Wolf D; Timmer, Jens; Klingmüller, Ursula (2009): Theoretical and experimental analysis links isoformspecific ERK signalling to cell fate decisions. Molecular Systems Biology, 5, doi:10.1038/msb.2009.91 |
Direitos |
CC-BY: Creative Commons Attribution 3.0 Unported Access constraints: unrestricted |
Palavras-Chave | #Detector raw counts; Event label; Experiment_ppERK_Treatment_a; Experiment_ppERK_Treatment_b; Experiment_ppERK_Treatment_c; Experiment_ppERK_Treatment_d; Thymidine incorporation; Treatment: Amount concentration, of Extracellular signal-Regulated Kinase 1; Treatment: Amount concentration, of Extracellular signal-Regulated Kinase 2; Treatment: Amount concentration, protein kinase B; Treatment: chemical concentration (biological activity), of Erythropoietin |
Tipo |
Dataset |